Ovarian Cancer
Ovarian Cancer Information for Patients and Health Professionals
Overview
Ovarian cancer is responsible for the highest mortality rates of all gynecologic cancers. It is expected that in 2007 an estimated 15,280 women will die from ovarian cancer and 22,430 new cases will be diagnosed. A decrease in incidence of 0.9% per year was reported between 1987 and 2004. Incidence and mortality rates are highest in white women compared to other racial and ethnic groups. Although highly treatable when detected early, most diagnoses occur at advanced stages of disease, when 5-year survival rates are 69% for patients with regionally advanced disease and 30% for patients with distant metastases.
- Gynecologic Cancers Topic Search — Cancer Topic Searches are prepared literature searches from the National Library of Medicine's PubMed database. Citations on a specific sub-category can be retrieved, or results limited by a date range.
Statistics
Ovarian cancer incidence, mortality, and survival, including analysis by race and ethnicity, and information about trends in NCI-funded ovarian cancer research.
- A Snapshot of Ovarian Cancer
- Fast Stats: Ovary Cancer
- Cancer Stat Fact Sheets: Ovary
- New Malignancies Following Cancer of the Uterine Corpus and Ovary (SEER Cancer Registries, 1973-2000)
NCI Research on Ovarian Cancer
Information about NCI-funded grants, clinical trials, and other programs and initiatives with components that primarily target ovarian cancer.
- Progress in Ovarian Cancer Research (NCI Women's Health Report FY 2005-2006)
- Ovarian Cancer Research Projects
- SPOREs in Ovarian Cancer (Specialized Programs of Research Excellence)
Biology and Genetics
- Ovarian Cancer Studies (Division of Cancer Epidemiology and Genetics)
- Mouse Models: Ovarian Cancer Models
- Cancer Genetics Network
- Clinical Trials in Ovarian Cancer Genetics
Risk Factors
Prevention
- Ovarian Cancer Prevention Programs (Division of Cancer Prevention)
- Clinical Trials in Ovarian Cancer Prevention
Early Detection, Diagnosis, and Prognosis
- Cancer Biomarkers Research Group (Division of Cancer Prevention)
- FDA/NCI Clinical Proteomics Program
- Frederick Cancer Research Center Biomedical Proteomics Program
- Clinical Trials in Ovarian Cancer Screening
- Clinical Trials in Ovarian Cancer Diagnosis
Treatment
Ovarian Cancer Reports
Reports on progress, gap areas, and recommended future directions in ovarian cancer research.